Review



vancomycin resistant enterococcus faecalis vre  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC vancomycin resistant enterococcus faecalis vre
    Vancomycin Resistant Enterococcus Faecalis Vre, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 539 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecium+(Orla-Jensen)+Schleifer+and+Kilpper-Balz/fda_document____cdrh_docs_slash_pdf17_slash_k172851-60-36-41
    Average 96 stars, based on 539 article reviews
    vancomycin resistant enterococcus faecalis vre - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Bacteria:

    Article Title:
    Article Snippet: .. Additionally, Test results have demonstrated preservative effectiveness against the following bacteria in solution, Proteus mirabilis (ATCC- 25933), Serratia marcescens (ATCC-8100), antibiotic resistant Methicillin-Resistant Staphylococcus aureus (MRSA) (ATCC-43300), Vancomycin-resistant Enterococcus faecalis (VRE) (ATCC-700221), and Acinetobacter baumannii (ATCC 19606). ..

    Article Title: Phytochemical profiling, in vitro biological activities, and in silico (molecular docking and absorption, distribution, metabolism, excretion, toxicity) studies of Polygonum cognatum Meissn.
    Article Snippet: All strain cultures were obtained from the American-Type Culture Collection (ATCC) and stored at −80◦C with 20% glycerol (w/v). .. Indicator strains used for assessment of antimicrobial activity were 5 Gram-positive [(Bacillus cereus (ATCC 14579), Staphylococcus aureus (ATCC 6538), Staphylococcus epidermidis (ATCC 1228), Methicillin-resistant Staphylococcus aureus (ATCC 33591) and vancomycin-resistant Enterococcus faecalis (VRE) (ATCC 51299)]; 4 Gramnegative bacteria [(Acinetobacter baumanii (ATCC 19606), Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC 4352), Salmonella typhimurium (ATCC 14028)] strains and a pathogenic yeast Candida albicans (ATCC 10231). .. All bacterial strains were activated on Tryptic Soy Agar at 37◦C (TSA, Oxoid) and the fungal strain was on Sabouraud 4% Dextrose Agar (SDA, Oxoid) at 30◦C for 24 h. 2.6.2 Agar spot on lawn assay A 100 μL fresh culture of indicator pathogenic strain (0.5 McFarland concentration [1 × 108 CFU/mL] in sterile tap water) inoculated by spreading over the medium.

    Article Title:
    Article Snippet: .. USP <51> testing was used to support preservative effectiveness of the product with the compendia organisms and the following bacteria in solution, Proteus mirabilis (ATCC- 25933), Serratia marcescens (ATCC-8100), antibiotic resistant Methicillin-Resistant Staphylococcus aureus (MRSA) (ATCC-43300), Vancomycin- resistant Enterococcus faecalis (VRE) (ATCC-700221), and Acinetobacter baumannii (ATCC 19606). ..

    In Vitro:

    Article Title: Pressure-Spun Fibrous Surgical Sutures for Localized Antibacterial Delivery: Development, Characterization, and In Vitro Evaluation.
    Article Snippet: .. The antibacterial properties of pressure-spun TPP fibrous surgical sutures and commercial Vicryl Plus sutures against Staphylococcus aureus (ATCC 6538P), vancomycin-resistant Enterococcus faecalis (VRE), and Escherichia coli (ATCC 11775) were determined with an in vitro agar diffusion test. ..

    Article Title: Pressure-Spun Fibrous Surgical Sutures for Localized Antibacterial Delivery: Development, Characterization, and In Vitro Evaluation
    Article Snippet: .. The antibacterial properties of pressure-spun TPP fibrous surgical sutures and commercial Vicryl Plus sutures against Staphylococcus aureus (ATCC 6538P), vancomycin-resistant Enterococcus faecalis (VRE), and Escherichia coli (ATCC 11775) were determined with an in vitro agar diffusion test. ..

    Diffusion-based Assay:

    Article Title: Pressure-Spun Fibrous Surgical Sutures for Localized Antibacterial Delivery: Development, Characterization, and In Vitro Evaluation.
    Article Snippet: .. The antibacterial properties of pressure-spun TPP fibrous surgical sutures and commercial Vicryl Plus sutures against Staphylococcus aureus (ATCC 6538P), vancomycin-resistant Enterococcus faecalis (VRE), and Escherichia coli (ATCC 11775) were determined with an in vitro agar diffusion test. ..

    Article Title: Pressure-Spun Fibrous Surgical Sutures for Localized Antibacterial Delivery: Development, Characterization, and In Vitro Evaluation
    Article Snippet: .. The antibacterial properties of pressure-spun TPP fibrous surgical sutures and commercial Vicryl Plus sutures against Staphylococcus aureus (ATCC 6538P), vancomycin-resistant Enterococcus faecalis (VRE), and Escherichia coli (ATCC 11775) were determined with an in vitro agar diffusion test. ..

    Activity Assay:

    Article Title: Phytochemical profiling, in vitro biological activities, and in silico (molecular docking and absorption, distribution, metabolism, excretion, toxicity) studies of Polygonum cognatum Meissn.
    Article Snippet: All strain cultures were obtained from the American-Type Culture Collection (ATCC) and stored at −80◦C with 20% glycerol (w/v). .. Indicator strains used for assessment of antimicrobial activity were 5 Gram-positive [(Bacillus cereus (ATCC 14579), Staphylococcus aureus (ATCC 6538), Staphylococcus epidermidis (ATCC 1228), Methicillin-resistant Staphylococcus aureus (ATCC 33591) and vancomycin-resistant Enterococcus faecalis (VRE) (ATCC 51299)]; 4 Gramnegative bacteria [(Acinetobacter baumanii (ATCC 19606), Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC 4352), Salmonella typhimurium (ATCC 14028)] strains and a pathogenic yeast Candida albicans (ATCC 10231). .. All bacterial strains were activated on Tryptic Soy Agar at 37◦C (TSA, Oxoid) and the fungal strain was on Sabouraud 4% Dextrose Agar (SDA, Oxoid) at 30◦C for 24 h. 2.6.2 Agar spot on lawn assay A 100 μL fresh culture of indicator pathogenic strain (0.5 McFarland concentration [1 × 108 CFU/mL] in sterile tap water) inoculated by spreading over the medium.

    Formulation:

    Article Title: Powdered collagen wound care compositions
    Article Snippet: .. A kill rate test of the 80/20 collagen wound care composition (formulation 3) was conducted on 20 g of formulation 3 against Pseudomonas aeruginosa (ATCC No. 9027), Staphylococcus epidermidis (ATCC No. 12228), Vancomycin-resistant Enterococcus faecalis (VRE) (ATCC No. 51575), and Salmonella enterica (ATCC No. 14028) at 8 hours and 24 hours. ..

    Article Title: Powdered collagen wound care compositions
    Article Snippet: .. A kill rate test of the 80/20 collagen wound care composition (formulation 3) was conducted on 20 g of formulation 3 against Pseudomonas aeruginosa (ATCC No. 9027), Staphylococcus epidermidis (ATCC No. 12228), Vancomycin-resistant Enterococcus faecalis (VRE) (ATCC No. 51575), and Salmonella enterica (ATCC No. 14028) at 8 hours and 24 hours. ..



    Similar Products

    96
    ATCC vancomycin resistant enterococcus faecalis vre
    Vancomycin Resistant Enterococcus Faecalis Vre, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecium+(Orla-Jensen)+Schleifer+and+Kilpper-Balz/fda_document____cdrh_docs_slash_pdf17_slash_k172851-60-36-41
    Average 96 stars, based on 1 article reviews
    vancomycin resistant enterococcus faecalis vre - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    ATCC vancomycin resistant enterococci vre atcc 51575 candida albicans atcc 10231 performance summary
    Vancomycin Resistant Enterococci Vre Atcc 51575 Candida Albicans Atcc 10231 Performance Summary, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecalis+(Andrewes+and+Horder)+Schleifer+and+Kilpper-Balz/fda_document____cdrh_docs_slash_pdf8_slash_k081246-11-41-44
    Average 99 stars, based on 1 article reviews
    vancomycin resistant enterococci vre atcc 51575 candida albicans atcc 10231 performance summary - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC 51299 vancomycin resistant vre
    51299 Vancomycin Resistant Vre, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecalis+(Andrewes+and+Horder)+Schleifer+and+Kilpper-Balz/pmc12488318-2-6-5
    Average 99 stars, based on 1 article reviews
    51299 vancomycin resistant vre - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    ATCC vancomycin resistant enterococcus faecalis vre strains
    Minimum inhibitory concentrations (MICs, mg/L) against drug‐resistant S. aureus and E. faecalis strains.
    Vancomycin Resistant Enterococcus Faecalis Vre Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecalis/pmc11635387-190-30-43
    Average 97 stars, based on 1 article reviews
    vancomycin resistant enterococcus faecalis vre strains - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    99
    ATCC vancomycin resistant enterococcus vre
    Minimum inhibitory concentrations (MICs, mg/L) against drug‐resistant S. aureus and E. faecalis strains.
    Vancomycin Resistant Enterococcus Vre, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecalis+(Andrewes+and+Horder)+Schleifer+and+Kilpper-Balz/us12161689-599-0-3
    Average 99 stars, based on 1 article reviews
    vancomycin resistant enterococcus vre - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC vancomycin resistant enterococcus faecalis vre atcc 51299
    Minimum inhibitory concentrations (MICs, mg/L) against drug‐resistant S. aureus and E. faecalis strains.
    Vancomycin Resistant Enterococcus Faecalis Vre Atcc 51299, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vancomycin+resistant+enterococcus+faecalis+vre/Enterococcus+faecalis+(Andrewes+and+Horder)+Schleifer+and+Kilpper-Balz/pm39032794-263-14-18
    Average 99 stars, based on 1 article reviews
    vancomycin resistant enterococcus faecalis vre atcc 51299 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Minimum inhibitory concentrations (MICs, mg/L) against drug‐resistant S. aureus and E. faecalis strains.

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: Minimum inhibitory concentrations (MICs, mg/L) against drug‐resistant S. aureus and E. faecalis strains.

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques:

    Minimum Inhibitory Concentrations (MICs, mg/l) of two selected compounds and four comparative agents against a panel of S. aureus (Panel A), E. faecalis (Panel B) and E. faecium (Panel C). Panel A ‐ All clinical strains of S. aureus (blue line), except for the final three standard S. aureus strains (ATCC 29213, ATCC 700698 and ATCC 700699, black line). MSSA = methicillin‐sensitive Staphylococcus aureus ; S = sensitive; GISA = glycopeptide‐intermediate S. aureus ; hGISA = hetero‐GISA; Panel B ‐ All clinical strains of E. faecalis (blue line), except for the final three ATCC/NTC strains (black line). VRE = vancomycin‐resistant enterococci; S = sensitive short for MSSA ‐ methicillin‐sensitive S. aureus ; Panel C ‐ VRE = vancomycin‐resistant enterococci; S = sensitive. Comparative agents: Van – Vancomycin; Lzd – Linezolid; Teic ‐ Teicoplanin; Dap – Daptomycin. A colour code was used based on the highest (in blue) to the lowest MIC value (in green) of the data set (the coloured bar, mg/l, is included on the left‐hand side of the picture). The highest range of the colour mapping was set to 2.00 (Panel A) or 4.00 (Panels B and C) for visualisation purposes.

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: Minimum Inhibitory Concentrations (MICs, mg/l) of two selected compounds and four comparative agents against a panel of S. aureus (Panel A), E. faecalis (Panel B) and E. faecium (Panel C). Panel A ‐ All clinical strains of S. aureus (blue line), except for the final three standard S. aureus strains (ATCC 29213, ATCC 700698 and ATCC 700699, black line). MSSA = methicillin‐sensitive Staphylococcus aureus ; S = sensitive; GISA = glycopeptide‐intermediate S. aureus ; hGISA = hetero‐GISA; Panel B ‐ All clinical strains of E. faecalis (blue line), except for the final three ATCC/NTC strains (black line). VRE = vancomycin‐resistant enterococci; S = sensitive short for MSSA ‐ methicillin‐sensitive S. aureus ; Panel C ‐ VRE = vancomycin‐resistant enterococci; S = sensitive. Comparative agents: Van – Vancomycin; Lzd – Linezolid; Teic ‐ Teicoplanin; Dap – Daptomycin. A colour code was used based on the highest (in blue) to the lowest MIC value (in green) of the data set (the coloured bar, mg/l, is included on the left‐hand side of the picture). The highest range of the colour mapping was set to 2.00 (Panel A) or 4.00 (Panels B and C) for visualisation purposes.

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques: Glycoproteomics

    Pre‐exposure of S. aureus and E.  faecalis  to quinoxaline analogues decreases their sensitivities.

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: Pre‐exposure of S. aureus and E. faecalis to quinoxaline analogues decreases their sensitivities.

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques: Analogues

    Pre‐exposure of S. aureus and E.  faecalis  to compounds 25 and 31 and impact on cross resistance to clinically available antibiotics.

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: Pre‐exposure of S. aureus and E. faecalis to compounds 25 and 31 and impact on cross resistance to clinically available antibiotics.

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques:

    MBC values of compounds 25 and 31 against S. aureus and E.  faecalis  .

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: MBC values of compounds 25 and 31 against S. aureus and E. faecalis .

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques:

    Quinoxaline analogues induce phenotypic alterations to the surface of both S. aureus and E. faecalis . Scanning electron micrographs of S. aureus ATCC 29213 (A–F) and E. faecalis NCTC 12201 (G–L). Panels A and G and Panels B and H represent untreated cells captured at 20,000‐ and 50,000‐times magnification, respectively. Bacteria treated with 2x MBC concentration of compound 25 are depicted in Panels C and I as well as Panels D and J at 20,000‐ and 50,000‐times magnification, respectively. Bacteria treated with 2 x MBC concentration of compound 31 are shown in Panels E and K as well as Panels F and L at 20,000‐ and 50,000‐times magnification, respectively. Blue arrows: loss of cellular content; red arrows: wrinkled cell surfaces; black arrow: cells that appear to have collapsed.

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: Quinoxaline analogues induce phenotypic alterations to the surface of both S. aureus and E. faecalis . Scanning electron micrographs of S. aureus ATCC 29213 (A–F) and E. faecalis NCTC 12201 (G–L). Panels A and G and Panels B and H represent untreated cells captured at 20,000‐ and 50,000‐times magnification, respectively. Bacteria treated with 2x MBC concentration of compound 25 are depicted in Panels C and I as well as Panels D and J at 20,000‐ and 50,000‐times magnification, respectively. Bacteria treated with 2 x MBC concentration of compound 31 are shown in Panels E and K as well as Panels F and L at 20,000‐ and 50,000‐times magnification, respectively. Blue arrows: loss of cellular content; red arrows: wrinkled cell surfaces; black arrow: cells that appear to have collapsed.

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques: Analogues, Bacteria, Concentration Assay

    Quinoxaline analogues showed better anti‐biofilm activities (MBEC) compared to five selected comparative antibiotics.

    Journal: MicrobiologyOpen

    Article Title: Compounds Containing 2,3‐Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin‐Resistant Staphylococcus aureus , Enterococcus faecalis , and Their Biofilms

    doi: 10.1002/mbo3.70011

    Figure Lengend Snippet: Quinoxaline analogues showed better anti‐biofilm activities (MBEC) compared to five selected comparative antibiotics.

    Article Snippet: Compound 22 f displayed activities against Neisseria gonorrhoeae (ATCC 49226; MIC of 1 mg/l), one flucloxacillin‐resistant S. aureus strain ( S. aureus NCTC 12493; MIC = 1 mg/L) and two vancomycin‐resistant Enterococcus faecalis (VRE) strains (NCTC 12201 ‐ MIC = 0.250 mg/L and ATCC 51299 ‐ MIC = 2 mg/L).

    Techniques: Analogues